The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the same amounts shown in the unaudited condensed consolidated statements of cash flows (in thousands):


	June 27, 2026		December 31, 2025		June 28, 2025		December 31, 2024
Cash and cash equivalents	$	171,369	$	203,890	$	103,497	$	131,913
Restricted cash, current	5,516		4,350		1,172		1,041
Restricted cash, non-current	9,250		9,291		12,600		12,600
Total cash, cash equivalents and restricted cash	$	186,135	$	217,531	$	117,269	$	145,554

Restricted cash includes cash held as collateral for stand-alone letter of credit agreements related to normal business transactions. The agreements require the Company to maintain specified amounts of cash as collateral in segregated accounts to support the letters of credit issued thereunder. As of June 27, 2026, the Company had $14.8 million in restricted cash, which was comprised of $12.6 million to secure the letter of credit delivered to the Company’s landlord as security for the performance of the Company’s obligations under its

Campus Lease, $1.2 million to secure the letter of credit associated with a third party contract manufacturer in Europe and $1.0 million to secure the letter of credit associated with the Company’s sales agreement with Roquette to purchase pea protein. See Note 1 2.